Kronos bio data presentation at eortc-nci-aacr symposium highlights the importance of p300 kat inhibition in hpv-driven tumors

– preclinical data demonstrate that inhibiting the p300 kat domain reactivates p53 in hpv-driven tumors resulting in anti-tumor activity – – preclinical data demonstrate that inhibiting the p300 kat domain reactivates p53 in hpv-driven tumors resulting in anti-tumor activity –
NCI Ratings Summary
NCI Quant Ranking